Walther E U, Dietrich E, Hohlfeld R
Neurologische Klinik und Poliklinik, Klinikum Grosshadern, München.
Nervenarzt. 1996 Jun;67(6):452-6.
Interferon beta-1b has been shown to reduce the frequency and severity of exacerbations in relapsing-remitting multiple sclerosis (MS). Unrealistic expectations of the patient and unexpected side effects may lead to discontinuation of the drug. Here we provide guidelines how to inform the patient adequately before therapy and discuss the most common side effects of interferon therapy.
β-1b干扰素已被证明可降低复发缓解型多发性硬化症（MS）病情加重的频率和严重程度。患者不切实际的期望和意外的副作用可能导致停药。在此，我们提供关于如何在治疗前充分告知患者的指南，并讨论干扰素治疗最常见的副作用。
